Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

Pharmaceutical Manufacturing and Supply – Benzonatate Capsules

Active

Federal

Response Deadline08/04/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract solicits the manufacture and supply of Benzonatate Capsules, USP, 100 mg, in bottles containing 100 units each, adhering strictly to FDA regulations, current Good Manufacturing Practices, and Department of Defense Defense Logistics Agency technical specifications. All packaging, labeling, and product documentation must comply with required NDC standards and DLA packaging guidelines to ensure full regulatory and logistical compatibility. The product must be produced in a facility certified for pharmaceutical manufacturing and capable of consistent quality control throughout the production lifecycle. This subcontract is issued under the NAICS code 325412 by the Department of Defense through the Medical Supply Chain Pharm FSA, with performance required at Fort Bragg, North Carolina, 28310. The solicitation was posted on July 29, 2026, and responses are due by August 4, 2026, with no set-aside provisions indicated. Interested parties must meet all technical and compliance requirements to be considered, with the expectation that the delivered product will be integrated into federal medical supply systems for distribution to military and defense healthcare facilities.

General Info

Manufacture and supply 100 mg Benzonatate Capsules per FDA, DLA, and NDC standards for DoD use.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

FORT BRAGG, NC, 28310, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 29

subcontract

Response DeadlineAug 4

Submission deadline

Response Deadline

08/04/2026, 05:00:00 PM UTCin 5 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Manufacture and supply of Benzonatate Capsules, USP, 100 mg, in bottles of 100 units, compliant with FDA, cGMP, and DLA technical specifications including NDC and packaging standards.

Similar Contracts

Same NAICS industry code

Pharmaceutical Tablet Supply – Sumatriptan Succinate 25mgThe contract entails the manufacture and supply of 54,000 units of Sumatriptan Succinate 25mg film-coated tablets intended for the acute treatment of migraines, with strict adherence to current Good Manufacturing Practices (cGMP) requirements to ensure product quality, safety, and consistency. The manufacturing process and final product must comply with controlled storage conditions to maintain stability and efficacy throughout the supply chain, reflecting the sensitive nature of pharmaceutical therapeutics. The procurement is structured as a subcontract under the NAICS code 325412, which designates pharmaceutical preparation manufacturing, and is managed by the Department of Defense through its Medical Supply Chain Pharm FSA agency, with performance required at Fort Bliss, Texas, 79918-2527. The solicitation was posted on July 29, 2026, with a response deadline of August 4, 2026, indicating a tight turn-around for qualified suppliers to submit proposals. The contract is not subject to any set-aside provisions and is publicly accessible via the DIBBS platform, suggesting a competitive bidding process open to eligible contractors capable of meeting federal pharmaceutical standards. Compliance with all regulatory, packaging, labeling, and documentation requirements for defense-related medical supplies will be mandatory, and delivery timelines will likely be tied to operational readiness needs of the military healthcare system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Benzoic Tincture, Compound, USP (NSN: 6505016549628)The contract entails the procurement and delivery of Benzoic Tincture, Compound, USP in bulk containers under the National Stock Number 6505016549628, with a response deadline of August 4, 2026. This is a subcontract issued by the Department of Defense through the Medical Supply Chain Pharm FSA, and the material must be delivered to a military address identified as APO with zip code 09094-3219. All supplies must strictly adhere to federal, military, and transportation regulations governing the packaging, labeling, and shipment of medical substances to ensure safety and compliance during transit. The work falls under the NAICS code 325412, indicating pharmaceutical manufacturing, and requires the vendor to meet all applicable standards for handling and transporting controlled medical products to government-operated facilities.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing and Packaging of Morphine Sulfate InjectionThe contract requires the manufacture, labeling, and packaging of Morphine Sulfate Injection at a concentration of 10mg/mL in 1x10 NEXJECT units, classified as a DEA Schedule II controlled substance, ensuring strict compliance with all applicable federal regulations including those set by the FDA, OSHA, and DLA. The product must adhere to precise quality, safety, and documentation standards appropriate for a high-risk controlled pharmaceutical, with packaging and labeling meeting all regulatory requirements for traceability, security, and handling. The work is to be performed at the designated place of performance in APO with ZIP code 09094-3219, under the oversight of the Department of Defense through the Medical Supply Chain Pharm FSA, and the solicitation is issued as a subcontract with a NAICS code of 325412 for pharmaceutical preparation manufacturing. Responses to this solicitation are due by August 4, 2026, with the opportunity published on July 29, 2026, indicating a limited bid window of one week. All proposals must demonstrate proven capability in handling DEA Schedule II substances, robust quality control systems, validated packaging processes, and full compliance with federal controlled substance handling protocols. The nature of the product and the federal context necessitate secure, auditable manufacturing practices with no tolerance for deviation from regulatory standards, and successful contractors must be equipped to meet the stringent demands of military medical supply chains while maintaining uninterrupted availability of this critical pain management medication.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Typhoid Vaccine Supply and PackagingThe contract involves the supply of 10 mL vials containing a modified, acellular Typhoid Vi Polysaccharide Vaccine, requiring full compliance with labeling, packaging, and hazardous materials documentation standards. The product must meet strict regulatory and safety specifications to ensure safe handling, transport, and administration, with all materials and processes aligned to industry and governmental requirements. The vaccine is intended for use within the Department of Defense’s medical supply chain, and the contractor is expected to deliver fully qualified and documented shipments to the designated performance location. The solicitation, issued under the NAICS code 325412 for pharmaceutical preparation manufacturing, is structured as a subcontract with a response deadline of August 4, 2026, and a posted date of July 29, 2026. Deliveries must be directed to FPO with ZIP code 96691-3300, reflecting its military logistics context. The contracting entity is the Medical Supply Chain Pharm FSA under the Department of Defense, indicating the vaccine will support military health operations. All aspects of the order, from manufacturing to documentation, must adhere to federal defense standards without reliance on set-aside provisions, and the contract is accessible via the DIBBS platform for official reference.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Silver Nitrate Applicators for Military Medical UseThe contract entails the manufacture and supply of sterile, individually packaged silver nitrate applicators compliant with stringent military medical standards, intended for use by U.S. Department of Defense medical personnel. These applicators must meet precise quality and safety requirements to ensure reliable performance in field and clinical settings, with delivery directed to DLA Troop Support facilities at Joint Base Pearl Harbor-Hickam, identified by zip code 96853-5256. The solicitation, categorized as a subcontract under NAICS code 325412, is issued by the Medical Supply Chain Pharm FSA under the Department of Defense and requires responses by August 3, 2026. All products must be packaged individually and meet the regulatory, sterilization, and labeling specifications dictated by military medical procurement guidelines to guarantee compatibility and safety in operational environments.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing and Supply – Albuterol Sulfate Inhalation AerosolThe contract requires the manufacture, packaging, labeling, and delivery of Albuterol Sulfate Inhalation Aerosol, identified by NSN 6505-01-543-6562, a metered-dose inhaler used for respiratory treatment. All activities must strictly adhere to regulatory standards set by the FDA, the Defense Logistics Agency, and OSHA to ensure product safety, efficacy, and compliance with federal requirements. The work is to be performed at Fort Campbell, with a zip code of 42223-5000, and falls under NAICS code 325412, which corresponds to pharmaceutical preparation manufacturing. The contract type is designated as a subcontract, and it was posted on July 29, 2026, with a response deadline of August 4, 2026. The procuring agency is the Department of Defense through the Medical Supply Chain Pharm FSA, indicating this is a defense-related procurement intended for military medical supply needs.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing and SupplyThe contract pertains to the manufacture and supply of Norethindrone and Ethinyl Estradiol Tablets, USP, a generic oral contraceptive, adhering strictly to FDA and USP standards to ensure quality, safety, and efficacy. The work is governed as a subcontract under the NAICS code 325412, indicating classification within pharmaceutical preparation manufacturing, and is solicited by the Department of Defense through the Medical Supply Chain Pharm FSA. The place of performance is designated as Richmond, Virginia, with a zip code of 23237-0000, specifying where the production and delivery activities must occur to meet contractual obligations. The solicitation was posted on July 29, 2026, with a firm response deadline of August 4, 2026, allowing bidders a seven-day window to submit proposals. This procurement aims to secure a reliable source of this essential contraceptive medication for military and federal health systems, requiring full regulatory compliance, consistent batch integrity, and adherence to the U.S. Pharmacopeia’s stringent specifications for active ingredients and finished dosage forms.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Supply – Paxlovid (Nirmatrelvir and Ritonavir Tablets)The contract involves the supply and delivery of 50 boxes of Paxlovid, containing Nirmatrelvir 300 mg and Ritonavir 100 mg tablets, for a total of 4,500 tablets, classified as a commercial off-the-shelf pharmaceutical product. The requirement is solicited under the Department of Defense through the Medical Supply Chain Pharm FSA, with the place of performance specified as Williamsburg, Virginia, 23185. The solicitation is structured as a subcontract and was posted on July 29, 2026, with responses due by August 4, 2026, indicating a competitive but time-sensitive procurement process. The NAICS code 325412 corresponds to pharmaceutical and biological product manufacturing, underscoring the regulated nature of the product and the need for compliance with industry standards for distribution and handling. The contract does not include any set-aside provisions, meaning it is open to all qualified suppliers without restriction based on business size or ownership category. Although no point of contact is listed, the official solicitation can be accessed through the DIBBS portal using the provided link. All deliveries must meet stringent pharmaceutical handling and validation requirements to ensure product integrity, and the supplier must guarantee adherence to current Good Manufacturing Practices and regulatory compliance throughout the supply chain. Timely delivery to the designated location is critical, as the product is intended for medical use within the DOD health system, and any failure to meet specifications or deadlines could impact patient care.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

NORETHINDRONE AND E

Solicitation # SPE2DP-26-T-4362

The contract pertains to the procurement of 1 mg norethindrone and 0.035 mg ethinyl estradiol tablets in a 28-tablet cycle format, with six cycles per package totaling 168 tablets per unit, designated as a single package unit of issue. The product must comply with stringent technical and quality requirements outlined in the DLA Master List of Technical and Quality Requirements, including adherence to the Medical Marking Standard No. 1 dated February 4, 2013, which supersedes MIL-STD-129. Shelf life is strictly limited to 36 months with no extensions permitted, and storage must be maintained at 20–25°C (68–77°F) as per USP controlled room temperature standards. Labeling must include the NSN, manufacturer, CAGE code, date of manufacture, expiration date, contract number, and lot number. Packaging must be commercial-grade, sealed to prevent damage or breakage, and shipped in suitable exterior containers to ensure safe, cost-effective delivery to the destination point under FOB destination terms. The item is manufactured by Teva Pharmaceuticals USA, Inc., with NDC 00555-9010-58, and is identified by NSN 6505-01-365-2363. Delivery is required within 20 days, with zero tolerance for variance in quantity, and inspection and acceptance occur at the destination. The solicitation is issued under contract number SPE2DP-26-T-4362, with a response deadline of August 4, 2026, and is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with Timothy McCauley listed as the primary point of contact.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4366

The contract specifies the procurement of MULTIPLE ELECTROLYTES INJECTION, TYPE 1, USP, in 1000 mL plastic bags, containing 14 units per case, with a pharmaceutical pH of 7.4. The product is manufactured by BAXTER HEALTHCARE CORPORATION under part number 2B2544X and is regulated by the FDA. It must be stored at room temperature, 25°C (77°F), with avoidance of excessive heat, and kept tightly closed in a cool, well-ventilated environment. The item has a non-extendable shelf life of 18 months as governed by RS001 for TYPE I (CODE K) classification and must be marked in accordance with the latest Medical Marking Standard No. 1. Packaging must comply with MIL-STD-2073-1E and the DLA packaging requirements, with latex-free plastic containers. The NSN is 6505014625492, and the unit of issue is PG, with a single unit ordered. Delivery is required within 20 days FOB destination, with zero tolerance for quantity variance and inspection and acceptance occurring at the destination. The solicitation number is SPE2DP-26-T-4366, issued by the Department of Defense’s Medical Supply Chain PHARM FSA with performance at Fort Bragg, North Carolina. Technical and quality requirements referenced under R numbers are governed by the DLA Master List of Technical and Quality Requirements, with revision control tied to the solicitation issue date. The contracting official must submit an EBS referral for FDA-regulated product confirmation, including bidder and manufacturer details. The contract was posted July 29, 2026, with a response deadline of August 4, 2026, under NAICS code 325412 for pharmaceutical preparation manufacturing.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ZINC OXIDE OINTMENT

Solicitation # SPE2DP-26-T-4364

The contract specifies the procurement of Zinc Oxide Ointment USP, a topical skin protectant containing 20% zinc oxide, supplied in collapsible tubes of 28.35 grams per unit, designated as a tube (TU). The product must be stored at controlled room temperature not exceeding 30°C (86°F) and has a non-extendable shelf life of 36 months as a Type I (Code Q) item. Packaging and labeling must strictly comply with MIL-STD-129 and the latest Medical Marking Standard No. 1, with all packaging requirements governed by the DLA Master List of Technical and Quality Requirements, which override ASTM D3951. The item is regulated by the FDA, requiring buyer referral for confirmation, and must be shipped via traceable means, excluding parcel post. All shipments are FOB destination with no quantity variance allowed, and inspection and acceptance occur at the delivery point. The item is identified by NSN 6505001501990 and manufacturer part number NDC67777-0223-11 from Dynarex Corp. Deliveries are split across six CLINs totaling 30 tubes, with delivery dates ranging from July 15 to July 30, 2026, directed to various military and government installations across the United States. Each delivery location has specific freight and marking instructions, including traceable carrier details and contract identifiers, and all must adhere to DLA packaging and palletization standards under RP001. The contract number is SPE2DP-26-T-4364 and the unit price is $3.00 per tube for all line items.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BENZONATATE CAPSULES

Solicitation # SPE2DP-26-T-4357

BENZONATATE CAPSULES, USP, 100 MG, are supplied in bottles of 100 capsules each, with the active ingredient being 100 milligrams of benzonatate per capsule. The product must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F) and protected from light, moisture, and humidity. This item falls under a Type I (Code Q) shelf-life classification with a non-extendable shelf life of 36 months and must be marked in accordance with the latest edition of Medical Marking Standard No. 1. It is regulated by the FDA, and buyers are required to submit a referral via EBS to the product specialist, including bidder and manufacturer details such as names, part numbers, and NDC codes. The item is subject to DLA packaging requirements and technical quality standards referenced in the DLA Master List of Technical and Quality Requirements. The contract specifies delivery of four bottles under purchase request 7017663196, with delivery due within 20 days FOB destination, no variance allowed in quantity, and inspection and acceptance occurring at the destination. The NSN is 6505-00-660-1798, and the solicitation number is SPE2DP-26-T-4357, issued by the Department of Defense’s Medical Supply Chain PHARM FSA, with a response deadline of August 4, 2026. Primary point of contact is Imerah Burnett, and packaging must comply with MIL-STD-2073-1E.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Small Business Subcontracting & Compliance SupportThe contract seeks a vendor to assist the prime contractor in achieving small business subcontracting objectives by identifying, coordinating with, and ensuring compliance for Women-Owned Small Businesses, Service-Disabled Veteran-Owned Small Businesses, and HUBZone certified firms. The support includes proactive outreach to eligible vendors, managing subcontractor relationships, and providing accurate and timely compliance reporting to meet federal small business participation targets. This effort is tied to a Department of Defense initiative under the Medical Supply Chain Pharm FSA, with performance centered at Fort Bliss, Texas, 79918-2527, and aligns with NAICS code 541611 for management consulting services. The opportunity is open for responses until August 4, 2026, with the solicitation posted on July 29, 2026. While no specific set-aside designation is indicated, the work is explicitly structured to enable prime contractors to fulfill their small business subcontracting obligations, particularly through engagement with certified disadvantaged and underrepresented business entities. The contracting vehicle falls under the subcontract category, and all activities must adhere to federal small business programs and reporting requirements applicable to Department of Defense contracts. Interested parties can access further details through the provided DIBBS portal link.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Domestic and International Pharmaceutical Shipping & Freight LogisticsThe contract requires the transport of temperature-sensitive pharmaceuticals under strict compliance with MIL-STD-247-7023 standards to ensure product integrity throughout the supply chain. All shipments must facilitate continuous chain-of-custody tracking, specifically for military delivery destinations, with Fort Bliss, Texas serving as the primary place of performance. The logistics provider must maintain rigorous documentation and real-time monitoring for both domestic and international movements, ensuring adherence to military-grade handling protocols for sensitive medical cargo. This is a subcontract opportunity under NAICS code 488510, managed by the Department of Defense through the Medical Supply Chain Pharm FSA, with proposals due by August 4, 2026.

Freight Transportation Arrangement

POSTED

DEADLINE

Pharmaceutical Packaging, Labeling, and PalletizationThe contract requires the packaging, labeling, and palletization of Sumatriptan tablets in full compliance with DLA standards, emphasizing light protection to preserve pharmaceutical integrity, MIL-STD-129 marking for uniform military identification, and adherence to RP001 and MIL-STD-2073-1E for secure and standardized palletization. All work must be performed to ensure logistical readiness and traceability within the Department of Defense supply chain. The project is classified as a subcontract under NAICS code 323111, with a response deadline of August 4, 2026, and the place of performance is designated as Fort Bliss, Texas, 79918-2527. The contracting activity falls under the Medical Supply Chain Pharm FSA within the Department of Defense, indicating its critical role in supporting military medical operations through reliable pharmaceutical logistics.

Commercial Printing (except Screen and Books)

POSTED

DEADLINE

Hazardous Materials Compliance & Safety Data Sheet (SDS) ManagementThe contract requires identification of hazardous components within pharmaceutical products and the preparation of Safety Data Sheets (SDS) that comply with OSHA’s Hazard Communication Standard and Federal Standard No. 313 to ensure regulatory alignment. All SDS documentation must meet precise technical and formatting requirements to support safe handling, storage, and disposal of hazardous pharmaceutical materials used within the Department of Defense supply chain. The work is scoped under subcontract and centered on ensuring compliance with federal safety regulations for materials processed or distributed through the Medical Supply Chain Pharm FSA. Performance is required at Fort Bliss, Texas, with a response deadline of August 4, 2026, and the contract falls under NAICS code 541690 for other scientific and technical consulting services. This effort supports the Department of Defense’s obligation to maintain safety and regulatory integrity across its pharmaceutical supply chain, emphasizing precision in hazard identification and standardized reporting. All deliverables must be accurate, timely, and fully aligned with current federal guidelines to facilitate seamless operations and regulatory audits.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Supplier of Ready-Made Pharmaceutical Packaging Compliant with DLA StandardsThe contract seeks a supplier to provide pre-approved, sealed pharmaceutical packaging that meets stringent military standards for medical-grade protection and durability, specifically complying with MIL-STD-2073-1E and DLA RP001. These requirements ensure the packaging maintains integrity under harsh environmental conditions, supports long-term storage, and safeguards pharmaceutical integrity during transport and deployment, particularly for use by U.S. military medical personnel. The packaging must be ready-made and fully compliant without requiring additional modification upon receipt. The opportunity is structured as a subcontract under the NAICS code 326199, with performance designated to occur at APO 09094-3219, indicating delivery to a U.S. military diplomatic or overseas location. The solicitation was posted on July 29, 2026, with a response deadline of August 4, 2026, providing a narrow seven-day window for submissions. The procuring entity is the Medical Supply Chain Pharm FSA under the Department of Defense, underscoring the critical nature of this supply for military health readiness. All proposals must align precisely with DLA specifications to ensure seamless integration into federal medical logistics systems.

All Other Plastics Product Manufacturing

POSTED

DEADLINE

Government Marking Removal for Non-Accepted SuppliesThe contract requires the removal of government markings from pharmaceutical supplies that have been rejected or not accepted, in accordance with DLA Clause RQ011, to ensure proper disposal or return procedures are followed. This task is critical to maintain compliance with federal regulations and protect sensitive information associated with government-issued materials. The work must be performed by a subcontractor under the authority of the Department of Defense's Medical Supply Chain Pharm FSA, with all activities centered at the designated place of performance in APO, ZIP 09094-3219. The solicitation is classified under NAICS code 562990 for other remediation services and is open for response until August 4, 2026, with the posting date listed as July 29, 2026. The subcontract nature of the agreement suggests the primary contractor will delegate the marking removal process, requiring precise adherence to handling protocols to avoid regulatory noncompliance or security breaches.

POSTED

DEADLINE

Cybersecurity and Covered Defense Information (CDI) SafeguardingThe contract requires the implementation and maintenance of cybersecurity controls to safeguard Covered Defense Information in accordance with NIST SP 800-171 and DFARS 252.204-7012, ensuring that all systems handling sensitive defense data meet federal standards for protection. This subcontract is aimed at securing information systems against unauthorized access, disclosure, or compromise, with specific focus on technical, administrative, and physical safeguards defined by the referenced frameworks. Compliance is mandatory and must be demonstrated throughout the performance period, with continuous monitoring and documentation of control effectiveness as a core expectation. The work is to be performed at the APO location with zip code 09094-3219, under the oversight of the Department of Defense through the Medical Supply Chain Pharm FSA. The solicitation was posted on July 29, 2026, with responses due by August 4, 2026, indicating a tight turnaround for proposers to demonstrate capability and readiness. The NAICS code 541512 identifies the work as related to computer systems design services, suggesting the need for specialized technical expertise in cybersecurity architecture and integration. All parties must be prepared to meet rigorous compliance standards, maintain audit-ready records, and ensure ongoing adherence to federal cybersecurity requirements without exception.

Computer Systems Design Services

POSTED

DEADLINE

Shelf-Life Monitoring and Inventory Management for Type I, Code K ItemsThe contract requires comprehensive management of shelf-life tracking and inventory rotation for Morphine Sulfate, a controlled Type I, Code K pharmaceutical item with a strict 18-month non-extendable shelf life, in full compliance with Defense Logistics Agency standards. All activities must ensure timely identification, labeling, and prioritized distribution of stock to prevent expiration and maintain regulatory compliance, with no tolerance for shelf-life extension or deviation from the established timeline. Performance is centered at APO, ZIP 09094-3219, under a subcontract structure governed by NAICS code 493110, with responses due by August 4, 2026. The contracting entity is the Department of Defense through the Medical Supply Chain Pharm FSA, and all operations must align with federal pharmaceutical logistics protocols to safeguard the integrity, security, and availability of this critical controlled substance within the military supply chain.

General Warehousing and Storage

POSTED

DEADLINE

Hazardous Materials Compliance and Safety Data Sheet (SDS) ManagementThe contract requires the preparation, maintenance, and timely submission of Safety Data Sheets for pharmaceutical components, ensuring full compliance with OSHA’s Hazard Communication Standard under 29 CFR 1910.1200. This includes accurate labeling of all hazardous materials to meet federal regulatory requirements, with a focus on consistency, clarity, and regulatory alignment throughout the supply chain. The work must be performed to support the Department of Defense’s Medical Supply Chain Pharmaceutical FSA, with performance centered at the APO zip code 09094-3219. This is a subcontract governed under NAICS code 541620, which corresponds to scientific and technical consulting services, indicating the need for specialized expertise in chemical safety and regulatory documentation. Responses are due by August 4, 2026, and the solicitation was posted on July 29, 2026. The contract does not specify a set-aside type or point of contact, and all work must be executed through the DIBBS platform using the provided solicitation number SPE2DP26T4360. Compliance with OSHA standards is non-negotiable, and any failure in SDS accuracy or labeling could result in regulatory violations and supply chain disruption.

Environmental Consulting Services

POSTED

DEADLINE